Effective vancomycin concentrations in children: a cross-sectional study

ABSTRACT Objective Analyze the microbiological effectiveness, based on the pharmacokinetics/pharmacodynamics correlation of vancomycin in pediatric patients, and to propose dose adjustment. Methods This is an observational, cross-sectional study, conducted in a pediatric hospital, over a 1-year...

Full description

Bibliographic Details
Main Authors: Geisa Cristina da Silva Alves, Farah Maria Drumond Chequer, Cristina Sanches
Format: Article
Language:English
Published: Instituto Israelita de Ensino e Pesquisa Albert Einstein
Series:Einstein (São Paulo)
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082019000100211&lng=en&tlng=en
id doaj-9ec4ee6b6b344b2aaa6240aa097d608b
record_format Article
spelling doaj-9ec4ee6b6b344b2aaa6240aa097d608b2020-11-24T22:26:11ZengInstituto Israelita de Ensino e Pesquisa Albert EinsteinEinstein (São Paulo)2317-638517110.31744/einstein_journal/2019ao4396S1679-45082019000100211Effective vancomycin concentrations in children: a cross-sectional studyGeisa Cristina da Silva AlvesFarah Maria Drumond ChequerCristina SanchesABSTRACT Objective Analyze the microbiological effectiveness, based on the pharmacokinetics/pharmacodynamics correlation of vancomycin in pediatric patients, and to propose dose adjustment. Methods This is an observational, cross-sectional study, conducted in a pediatric hospital, over a 1-year period (2016 to 2017). Children of both sexes, aged 2 to 12 years, were included in the study; burn children, and children in renal replacement therapy were excluded. For the pharmacokinetic analysis, two samples of 2mL of whole blood were collected, respecting the 2-hour interval between each withdrawal. Results Ten pediatric patients with median age of 5.5 years and interquartile range (IQR) of 3.2-9.0 years, median weight of 21kg (IQR: 15.5-24.0kg) and median height of 112.5cm (IQR: 95-133cm), were included. Only one child achieved trough concentrations between 10µg/mL and 15µg/mL. Conclusion The empirical use of vancomycin in the children studied did not achieve the therapeutic pharmacokinetic/pharmacodynamic target for minimum inhibitory concentration of 1µg/mL.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082019000100211&lng=en&tlng=enTestes de sensibilidade microbianaFarmacocinéticaAções farmacológicasVancomicinaCriança
collection DOAJ
language English
format Article
sources DOAJ
author Geisa Cristina da Silva Alves
Farah Maria Drumond Chequer
Cristina Sanches
spellingShingle Geisa Cristina da Silva Alves
Farah Maria Drumond Chequer
Cristina Sanches
Effective vancomycin concentrations in children: a cross-sectional study
Einstein (São Paulo)
Testes de sensibilidade microbiana
Farmacocinética
Ações farmacológicas
Vancomicina
Criança
author_facet Geisa Cristina da Silva Alves
Farah Maria Drumond Chequer
Cristina Sanches
author_sort Geisa Cristina da Silva Alves
title Effective vancomycin concentrations in children: a cross-sectional study
title_short Effective vancomycin concentrations in children: a cross-sectional study
title_full Effective vancomycin concentrations in children: a cross-sectional study
title_fullStr Effective vancomycin concentrations in children: a cross-sectional study
title_full_unstemmed Effective vancomycin concentrations in children: a cross-sectional study
title_sort effective vancomycin concentrations in children: a cross-sectional study
publisher Instituto Israelita de Ensino e Pesquisa Albert Einstein
series Einstein (São Paulo)
issn 2317-6385
description ABSTRACT Objective Analyze the microbiological effectiveness, based on the pharmacokinetics/pharmacodynamics correlation of vancomycin in pediatric patients, and to propose dose adjustment. Methods This is an observational, cross-sectional study, conducted in a pediatric hospital, over a 1-year period (2016 to 2017). Children of both sexes, aged 2 to 12 years, were included in the study; burn children, and children in renal replacement therapy were excluded. For the pharmacokinetic analysis, two samples of 2mL of whole blood were collected, respecting the 2-hour interval between each withdrawal. Results Ten pediatric patients with median age of 5.5 years and interquartile range (IQR) of 3.2-9.0 years, median weight of 21kg (IQR: 15.5-24.0kg) and median height of 112.5cm (IQR: 95-133cm), were included. Only one child achieved trough concentrations between 10µg/mL and 15µg/mL. Conclusion The empirical use of vancomycin in the children studied did not achieve the therapeutic pharmacokinetic/pharmacodynamic target for minimum inhibitory concentration of 1µg/mL.
topic Testes de sensibilidade microbiana
Farmacocinética
Ações farmacológicas
Vancomicina
Criança
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082019000100211&lng=en&tlng=en
work_keys_str_mv AT geisacristinadasilvaalves effectivevancomycinconcentrationsinchildrenacrosssectionalstudy
AT farahmariadrumondchequer effectivevancomycinconcentrationsinchildrenacrosssectionalstudy
AT cristinasanches effectivevancomycinconcentrationsinchildrenacrosssectionalstudy
_version_ 1725754317091110912